TY - GEN
T1 - Efficient Classification of Multiple Sclerosis and Idiopathic Transverse Myelitis Using CNN Feature Extraction and Walrus Optimizer on MRI Scans
AU - Khattap, Mohamed G.
AU - Abd Elaziz, Mohamed
AU - Bekheet, Mohamed
AU - El-Sayed, Mohamed Zakaria
AU - Dahou, Abdelghani
AU - Ahmed Eleraky, Hassan
AU - Galal Eldeen Mohamed Ali Hassan, Hend
N1 - Publisher Copyright:
© 2024 IEEE.
PY - 2024
Y1 - 2024
N2 - Acute myelopathies, including Multiple Sclerosis (MS) and Idiopathic Transverse Myelitis (ITM), present significant diagnostic challenges due to overlapping clinical and imaging features. Accurate differentiation between these conditions and normal individuals is crucial for timely and appropriate treatment. In this study, we propose a method that utilizes Convolutional Neural Networks (CNNs), specifically ResNet50 and DenseNet201, to extract features from MRI images, followed by feature selection using the Walrus Optimizer for classification of MS, ITM, and healthy controls. A dataset of 2,746 MR images, including 128 MS patients, 131 ITM patients, and 150 healthy controls, was used for training and validation. The dataset, consisting of sagittal and axial views, captures the unique lesion characteristics of each condition, such as the length and location of spinal lesions. Our approach achieved an accuracy of over 90%, demonstrating the effectiveness of CNN-based feature extraction combined with advanced optimization techniques. This AI-driven method offers a significant advancement in non-invasive diagnostics, potentially reducing the need for additional procedures and enabling earlier and more precise clinical interventions. Our findings highlight the potential of combining CNNs with feature selection algorithms in the field of medical imaging, providing a reliable tool for the differentiation of complex neurological disorders.
AB - Acute myelopathies, including Multiple Sclerosis (MS) and Idiopathic Transverse Myelitis (ITM), present significant diagnostic challenges due to overlapping clinical and imaging features. Accurate differentiation between these conditions and normal individuals is crucial for timely and appropriate treatment. In this study, we propose a method that utilizes Convolutional Neural Networks (CNNs), specifically ResNet50 and DenseNet201, to extract features from MRI images, followed by feature selection using the Walrus Optimizer for classification of MS, ITM, and healthy controls. A dataset of 2,746 MR images, including 128 MS patients, 131 ITM patients, and 150 healthy controls, was used for training and validation. The dataset, consisting of sagittal and axial views, captures the unique lesion characteristics of each condition, such as the length and location of spinal lesions. Our approach achieved an accuracy of over 90%, demonstrating the effectiveness of CNN-based feature extraction combined with advanced optimization techniques. This AI-driven method offers a significant advancement in non-invasive diagnostics, potentially reducing the need for additional procedures and enabling earlier and more precise clinical interventions. Our findings highlight the potential of combining CNNs with feature selection algorithms in the field of medical imaging, providing a reliable tool for the differentiation of complex neurological disorders.
KW - Artificial Intelligence
KW - Feature Selection and Deep Learning
KW - Multiple Sclerosis
KW - Transverse Myelitis
KW - Walrus Optimizer
UR - https://www.scopus.com/pages/publications/105012102564
U2 - 10.1109/CSDGAIS64098.2024.11064825
DO - 10.1109/CSDGAIS64098.2024.11064825
M3 - Conference contribution
AN - SCOPUS:105012102564
T3 - 2024 International Conference on Smart-Digital-Green Technologies and Artificial Intelligence Sciences, CSDGAIS 2024
BT - 2024 International Conference on Smart-Digital-Green Technologies and Artificial Intelligence Sciences, CSDGAIS 2024
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 2024 International Conference on Smart-Digital-Green Technologies and Artificial Intelligence Sciences, CSDGAIS 2024
Y2 - 9 December 2024 through 11 December 2024
ER -